UTI Healthcare Fund Direct-growth

  • 3 Months
  • 6 Months
  • 1 Year
  • 3 Years
  • 5 Years
  • RSI
3 Months Returns : 2.15%
NAV: ₹328.87 as on Fri Oct 31, 2025
Fund NAV

Fund Overview of UTI Healthcare Fund Direct-growth

  • ₹1,146.1 Cr
    AUM
  • ₹328.87
    NAV
  • 1.29%
    Expense Ratio
  • Equity
    Fund Category
As on Fri Oct 31, 2025

Returns of UTI Healthcare Fund Direct-growth

Tenure Absolute(%) Annualised(%) Category Average(%)
3 Months 2.15% NA 6.12%
6 Months 15.71% NA 12.92%
1 Year 2.33% 2.33% 6.04%
2 Years 62.77% 27.58% 24.93%
3 Years 98.91% 25.76% 25.71%
5 Years 131.86% 18.32% 19.91%
7 Years 263.31% 20.24% NA
10 Years 217.01% 12.23% 12.78%
View More
As on Fri Oct 31, 2025

Asset Allocation

equities

98.98%

debt instruments

0.01%

other assets or cash equivalents

1.02%
Large Cap: 33.47%
Mid Cap: 25.29%
Small Cap: 41.24%
Other: 0.00%
Top Holdings
Sun Pharmaceutical Industries Ltd
9.84%
Sun Pharmaceutical Industries Ltd
9.61%
Cipla Ltd
5.43%
Ajanta Pharma Ltd
5.48%
Cipla Ltd
5.48%
 
Top Sectors
Healthcare
196.63%
Unspecified
3.37%
Detailed Portfolio Analysis
As on Fri Oct 31, 2025
Invest Now

About Fund

About UTI Healthcare Fund Direct-growth

UTI Healthcare Fund Direct-growth is one Equity mutual fund offered by UTI Mutual Fund. the fund aims Long term capital appreciation. Investment in equity instruments following a value investment strategy across the market capitalization spectrum. It manages assets worth ₹1,146.1 crore as on Thu Jul 31, 2025. , with a 52-week NAV range between ₹278.56 and ₹338.07. The expense ratio stands at 1.29%.
The portfolio allocation consists of 98.98% in equities, 0.01% in debt instruments, 1.02% in other assets or cash equivalents. Managed by Kamal Gada, it has delivered a return of 2.33% in the last year, a total return since inception of 16.36%.

Read more
  • Kamal Gada

    Fund Manager

  • Mr. Gada is B.com, CA, CS, & CFA

    Manager Education

Key Metrics of UTI Healthcare Fund Direct-growth

  • Standard Deviation
    15.67%
  • Sharpe Ratio
    1.17%
  • Alpha
    2.04%
  • Beta
    0.95%

Fund Details

Fund Names UTI Healthcare Fund Direct-growth
Lock In No Lock-in
SIP Minimum Investment amount ₹ 500
SWP Minimum Investment amount ₹ 500
STP Minimum Investment amount ₹ 100
 
Risk Principal at very high risk
Category Average Annual Returns 6.04
52 Weeks High 338.07
52 Weeks Low 278.56
More Details
Highest NAV in last 52 weeks & Lowest NAV in last 52 weeks

Top Performing Mutual Funds

Fund Names AUM (Cr) 1M 3M 1Yr 3Yr 5Yr
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth trend ₹6,104 3.76% -1.49% 5.42% 28.08% 21.90%
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth trend ₹6,104 3.70% -1.70% 4.56% 27.00% 20.85%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth trend ₹872 2.34% -2.18% -0.15% 22.26% 17.84%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth trend ₹872 2.21% -2.49% -1.43% 20.63% 16.17%
increase growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns

More funds from UTI Mutual Fund

Fund Names AUM (Cr) 1M 3M 6M 1Yr 3Yr
UTI Healthcare Fund Regular Plan-growth increase ₹1,146 2.30% -1.97% 7.65% 2.00% 23.73%
UTI Healthcare Fund Regular Plan-idcw increase ₹1,146 2.30% -1.97% 7.65% 2.00% 23.73%
UTI Healthcare Fund Direct-idcw increase ₹1,146 2.38% -1.73% 8.19% 3.03% 24.96%
increase growth is based on 1-month returns of the funds

Mutual Fund Calculator

I want to invest Pro Tip
Financial experts suggest that a person should invest 10-15% of their monthly income for long-term financial growth
/Month
I want to invest for Pro Tip
Financial experts suggest that individuals should ideally invest for a period of 5 to 10 years, or even longer, to maximize the benefits of compounding and navigate market fluctuations effectively
Years
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 29
  • 31
  • 32
  • 33
  • 34
  • 36
  • 37
  • 38
  • 39
  • 40
Expected return Pro Tip
Top 25% of investors consistently generate more than 12% return
% Annually
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 30
Total Investment
Wealth Gained
Total Wealth
Start Investing
I want to save
I want to invest for Pro Tip
Financial experts suggest that individuals should ideally invest for a period of 5 to 10 years, or even longer, to maximize the benefits of compounding and navigate market fluctuations effectively
Years
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 29
  • 31
  • 32
  • 33
  • 34
  • 36
  • 37
  • 38
  • 39
  • 40
Expected return Pro Tip
Top 25% of investors consistently generate more than 12% return
% Annually
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 30
Total Investment
Wealth Gained
Monthly Investment
Invest Now
You can also get Tax Free Maturity/ Returns? You can also get Tax Free Maturity/ Returns?

Top Mutual Funds

Fund Names AUM (Cr) NAV 3Yr 5Yr 10Yr
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth trend ₹6,104 ₹43.58 28.08% 21.90% -
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth trend ₹6,104 ₹40.36 27.00% 20.85% -
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth trend ₹872 ₹31.00 20.63% 16.17% -
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth trend ₹872 ₹34.16 22.26% 17.84% -
Aditya Birla Sun Life Nifty Healthcare Etf-growth trend ₹37 ₹15.07 21.24% - -
Aditya Birla Sun Life Nifty Healthcare Etf-growth trend ₹37 ₹15.07 21.24% - -
Aditya Birla Sun Life Nifty Healthcare Etf-growth trend ₹37 ₹15.07 21.24% - -
Aditya Birla Sun Life Nifty Healthcare Etf-growth trend ₹37 ₹15.07 21.24% - -
View More
Top funds are based on Fund AUM

Detailed Portfolio

Stocks Sector % of Holding Value
Sun Pharmaceutical Industries LtdHealthcare9.84%₹112.82 Cr
Sun Pharmaceutical Industries LtdHealthcare9.61%₹105.39 Cr
Cipla LtdHealthcare5.43%₹62.18 Cr
Ajanta Pharma LtdHealthcare5.48%₹60.16 Cr
Cipla LtdHealthcare5.48%₹60.13 Cr
Ajanta Pharma LtdHealthcare4.80%₹55.03 Cr
Lupin LtdHealthcare4.70%₹51.61 Cr
Lupin LtdHealthcare4.29%₹49.19 Cr
Procter & Gamble Health LtdHealthcare4.13%₹47.33 Cr
Dr. Reddy's Laboratories LtdHealthcare3.99%₹45.73 Cr
Procter & Gamble Health LtdHealthcare3.99%₹43.72 Cr
Glenmark Pharmaceuticals LtdHealthcare3.74%₹41.01 Cr
Dr. Reddy's Laboratories LtdHealthcare3.74%₹40.99 Cr
Glenmark Pharmaceuticals LtdHealthcare3.54%₹40.55 Cr
Fortis Healthcare LtdHealthcare3.48%₹39.87 Cr
Apollo Hospitals Enterprise LtdHealthcare3.47%₹39.74 Cr
Gland Pharma LtdHealthcare3.62%₹39.69 Cr
Apollo Hospitals Enterprise LtdHealthcare3.58%₹39.27 Cr
Alkem Laboratories LtdHealthcare3.56%₹39.06 Cr
Fortis Healthcare LtdHealthcare3.54%₹38.79 Cr
Jupiter Life Line Hospitals Ltd.Healthcare3.15%₹34.52 Cr
Gland Pharma LtdHealthcare3.01%₹34.45 Cr
Divi's Laboratories LtdHealthcare2.88%₹32.98 Cr
Eris Lifesciences LtdHealthcare2.81%₹32.23 Cr
Jupiter Life Line Hospitals Ltd.Healthcare2.81%₹32.18 Cr
Suven Pharmaceuticals LtdHealthcare2.89%₹31.66 Cr
Caplin Point Laboratories LtdHealthcare2.70%₹31.00 Cr
Max Healthcare Institute LtdHealthcare2.61%₹29.90 Cr
Krishna Institute Of Medical Sciences LtdHealthcare2.55%₹29.22 Cr
Suven Pharmaceuticals LtdHealthcare2.53%₹28.96 Cr
Aurobindo Pharma LtdHealthcare2.49%₹28.50 Cr
Divi's Laboratories LtdHealthcare2.59%₹28.45 Cr
Eris Lifesciences LtdHealthcare2.59%₹28.41 Cr
Alkem Laboratories LtdHealthcare2.41%₹27.67 Cr
Aurobindo Pharma LtdHealthcare2.47%₹27.10 Cr
Net Current AssetsUnspecified2.34%₹26.78 Cr
Max Healthcare Institute LtdHealthcare2.44%₹26.75 Cr
Caplin Point Laboratories LtdHealthcare2.35%₹25.72 Cr
Krishna Institute Of Medical Sciences LtdHealthcare2.25%₹24.72 Cr
Ipca Laboratories LtdHealthcare1.98%₹22.64 Cr
Ipca Laboratories LtdHealthcare1.92%₹21.04 Cr
Sai Life Sciences Ltd.Healthcare1.78%₹20.43 Cr
Sai Life Sciences Ltd.Healthcare1.80%₹19.76 Cr
Metropolis Healthcare LtdHealthcare1.80%₹19.69 Cr
Global Health LtdHealthcare1.77%₹19.44 Cr
Pfizer LtdHealthcare1.77%₹19.44 Cr
Metropolis Healthcare LtdHealthcare1.69%₹19.41 Cr
Global Health LtdHealthcare1.69%₹19.40 Cr
Aster Dm Healthcare LtdHealthcare1.74%₹19.12 Cr
Aster Dm Healthcare LtdHealthcare1.61%₹18.45 Cr
Emcure Pharmaceuticals Ltd.Healthcare1.53%₹17.56 Cr
Marksans Pharma LtdHealthcare1.50%₹17.17 Cr
Sequent Scientific LtdHealthcare1.48%₹16.23 Cr
Anthem Biosciences Ltd.Healthcare1.46%₹16.02 Cr
Anthem Biosciences Ltd.Healthcare1.39%₹15.98 Cr
Windlas Biotech LtdHealthcare1.39%₹15.87 Cr
Pfizer LtdHealthcare1.33%₹15.27 Cr
Sequent Scientific LtdHealthcare1.31%₹14.98 Cr
Biocon LtdHealthcare1.29%₹14.83 Cr
Windlas Biotech LtdHealthcare1.33%₹14.54 Cr
Vijaya Diagnostic Centre LtdHealthcare1.13%₹12.90 Cr
Syngene International LtdHealthcare1.12%₹12.85 Cr
Marksans Pharma LtdHealthcare1.14%₹12.46 Cr
Vijaya Diagnostic Centre LtdHealthcare1.09%₹12.00 Cr
Rainbow Childrens Medicare LtdHealthcare1.05%₹11.99 Cr
Biocon LtdHealthcare1.09%₹11.94 Cr
Ami Organics LtdHealthcare1.03%₹11.84 Cr
Ami Organics LtdHealthcare1.07%₹11.76 Cr
Sanofi Consumer Healthcare India LtdHealthcare1.02%₹11.68 Cr
Sanofi Consumer Healthcare India LtdHealthcare1.03%₹11.30 Cr
Torrent Pharmaceuticals LtdHealthcare0.98%₹11.23 Cr
Syngene International LtdHealthcare1.02%₹11.21 Cr
Net Current AssetsUnspecified1.02%₹11.14 Cr
Torrent Pharmaceuticals LtdHealthcare0.99%₹10.81 Cr
Jubilant Pharmova LtdHealthcare0.93%₹10.71 Cr
Alembic Pharmaceuticals LtdHealthcare0.93%₹10.69 Cr
Rainbow Childrens Medicare LtdHealthcare0.97%₹10.66 Cr
Alembic Pharmaceuticals LtdHealthcare0.90%₹9.86 Cr
Jubilant Pharmova LtdHealthcare0.88%₹9.68 Cr
Emcure Pharmaceuticals Ltd.Healthcare0.88%₹9.60 Cr
Orchid Pharma LtdHealthcare0.65%₹7.40 Cr
Orchid Pharma LtdHealthcare0.64%₹7.02 Cr
Laxmi Dental Ltd.Healthcare0.56%₹6.44 Cr
Laxmi Dental Ltd.Healthcare0.45%₹4.96 Cr
Others CbloUnspecified0.01%₹0.10 Cr
Others CbloUnspecified0.01%₹0.10 Cr
View More

Top Equity Funds

Fund Names NAV 3Yr 5Yr 52 weeks high
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth increase ₹43.58 28.08% 21.90% 44.69
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth increase ₹40.36 27.00% 20.85% 41.47
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth increase ₹34.16 22.26% 17.84% -
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth increase ₹31.00 20.63% 16.17% -
increase growth is based on 5Y returns of the funds

Frequently Asked Questions

UTI Healthcare Fund Direct-growth

What is the current AUM of UTI Healthcare Fund Direct-growth?

As of Thu Jul 31, 2025, UTI Healthcare Fund Direct-growth manages assets worth ₹1,146.1 crore

How has UTI Healthcare Fund Direct-growth performed recently?

  • 3 Months: 2.15%
  • 6 Months: 15.71%

What is the long-term performance of UTI Healthcare Fund Direct-growth?

  • 3 Years CAGR: 25.76%
  • 5 Years CAGR: 18.32%
  • Since Inception: 16.36%

What is the portfolio composition of UTI Healthcare Fund Direct-growth?

Equity: 98.98%, Debt: 0.01%, Others: 1.02%.

Who manages UTI Healthcare Fund Direct-growth?

UTI Healthcare Fund Direct-growth is managed by Kamal Gada from UTI Mutual Fund.

What is the market-cap allocation of UTI Healthcare Fund Direct-growth?

Large Cap: 33.47%, Mid Cap: 25.29%, Small Cap: 41.24%.

Which are the top companies UTI Healthcare Fund Direct-growth has invested in?

  • Sun Pharmaceutical Industries Ltd – 9.84% of the fund's portfolio
  • Sun Pharmaceutical Industries Ltd – 9.61% of the fund's portfolio
  • Cipla Ltd – 5.43% of the fund's portfolio
  • Ajanta Pharma Ltd – 5.48% of the fund's portfolio
  • Cipla Ltd – 5.48% of the fund's portfolio

Which are the major sectors UTI Healthcare Fund Direct-growth focuses on?

  • Healthcare – 196.63% of the fund's portfolio
  • Unspecified – 3.37% of the fund's portfolio
View more FAQ's

Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.

Please consult your financial advisor for an informed decision.

Past performance may not be indicative of future results.

The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.

Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.

Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.

Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.

For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.

For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.

Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved

^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.

Explore the popular searches and stay informed

Close
Download the Policybazaar app
to manage all your insurance needs.
INSTALL
Claude
top

Become a Crorepati

Invest ₹10K/Month & Get ₹1 Crore# Returns

Mobile +91
*T&C Applied.